StreetInsider.com News Articles

Form 6-K NovaBridge Biosciences For: Jul 24

Fri, 24 Jul 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260724/26814253.html

Form 6-K NovaBridge Biosciences For: Jul 24

Fri, 24 Jul 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260724/26814253.html

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

Fri, 24 Jul 2026 17:00:00 -0400

ROCKVILLE, Md., July 24, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (“NovaBridge” or the “Company”), a clinical-stage biopharmaceutical company advancing innovative medicines for areas of significant unmet need, today announced that it will hold its annual general meeting of shareholders (the “AGM”) at NovaBridge Biosciences Shanghai office, 38F, AIA Tower, No. 866 Dongchangzhi Road, Shanghai, China on September 8, 2026 at 10:00 a.m. (Shanghai time).

Holders of record of ordinary shares of a par value of US$0.0001 each of the Company at the close of business on July 27, 2026 (Shanghai time) are entitled

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

Fri, 24 Jul 2026 17:00:00 -0400

Holders of record of ordinary shares of a par value of US$0.0001 each of the Company at the close of business on July 27, 2026 (Shanghai time) are entitled

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

Fri, 24 Jul 2026 17:00:00 -0400

Holders of record of ordinary shares of a par value of US$0.0001 each of the Company at the close of business on July 27, 2026 (Shanghai time) are entitled

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

Fri, 24 Jul 2026 17:00:00 -0400

Holders of record of ordinary shares of a par value of US$0.0001 each of the Company at the close of business on July 27, 2026 (Shanghai time) are entitled

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

Fri, 24 Jul 2026 17:00:00 -0400

Holders of record of ordinary shares of a par value of US$0.0001 each of the Company at the close of business on July 27, 2026 (Shanghai time) are entitled

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

Fri, 24 Jul 2026 17:00:00 -0400

Holders of record of ordinary shares of a par value of US$0.0001 each of the Company at the close of business on July 27, 2026 (Shanghai time) are entitled

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

Fri, 24 Jul 2026 17:00:00 -0400

Holders of record of ordinary shares of a par value of US$0.0001 each of the Company at the close of business on July 27, 2026 (Shanghai time) are entitled

NovaBridge Biosciences to Hold Annual General Meeting on September 8, 2026

Fri, 24 Jul 2026 17:00:00 -0400

Holders of record of ordinary shares of a par value of US$0.0001 each of the Company at the close of business on July 27, 2026 (Shanghai time) are entitled

Form 6-K NovaBridge Biosciences For: Jul 13

Fri, 17 Jul 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260717/26781547.html

Form 6-K NovaBridge Biosciences For: Jul 13

Fri, 17 Jul 2026 06:04:00 -0400

si-local-file:///var/storage/secattach/20260717/26781547.html

Form 4 NovaBridge Biosciences For: Jul 08 Filed by: Lin Liwei Lorraine

Fri, 10 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260710/26757899.html

Form 4 NovaBridge Biosciences For: Jul 08 Filed by: Lin Liwei Lorraine

Fri, 10 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260710/26757899.html

Form 4 NovaBridge Biosciences For: Jul 08 Filed by: Hagler Mark Arnold

Fri, 10 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260710/26757908.html

Form 4 NovaBridge Biosciences For: Jul 08 Filed by: Hagler Mark Arnold

Fri, 10 Jul 2026 17:00:00 -0400

si-local-file:///var/storage/secattach/20260710/26757908.html

Form 4 NovaBridge Biosciences For: Jul 06 Filed by: Gupta Srishti

Wed, 08 Jul 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260708/26747861.html

Form 4 NovaBridge Biosciences For: Jul 06 Filed by: Gupta Srishti

Wed, 08 Jul 2026 16:26:00 -0400

si-local-file:///var/storage/secattach/20260708/26747861.html

Form 3 NovaBridge Biosciences For: Jul 01 Filed by: Gupta Srishti

Wed, 08 Jul 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260708/26747843.html

Form 3 NovaBridge Biosciences For: Jul 01 Filed by: Gupta Srishti

Wed, 08 Jul 2026 16:24:00 -0400

si-local-file:///var/storage/secattach/20260708/26747843.html

Form 4 NovaBridge Biosciences For: Jul 04 Filed by: Xu Cong Claire

Tue, 07 Jul 2026 19:50:00 -0400

si-local-file:///var/storage/secattach/20260707/26743068.html

Form 4 NovaBridge Biosciences For: Jul 04 Filed by: Xu Cong Claire

Tue, 07 Jul 2026 19:50:00 -0400

si-local-file:///var/storage/secattach/20260707/26743068.html

Form 4 NovaBridge Biosciences For: Jun 29 Filed by: Fu Wei

Tue, 30 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260630/26713799.html

Form 4 NovaBridge Biosciences For: Jun 29 Filed by: Fu Wei

Tue, 30 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260630/26713799.html

NovaBridge Biosciences names new CEO, replacing Xi-Yong Fu

Mon, 29 Jun 2026 07:02:07 -0400

NovaBridge Biosciences (Nasdaq: NBP) announced the appointment of Srishti Gupta, MD MPP, as Chief Executive Officer and a member of its Board of Directors, effective July 1, 2026.

Xi-Yong (Sean) Fu, who previously held the CEO role, will step down to pursue other opportunities. Fu will remain with the company in an advisory capacity during the transition.

Dr. Gupta most recently served as CEO of Idorsia Ltd, a Switzerland-based biopharmaceutical company, where she executed an operational and financial turnaround after four years on its board. Prior to that, she spent 18 years at McKinsey & Company, leading the firm's Global Health Practice